Symmans WF - Search Results

1

Seventeen-gene signature from enriched Her2/Neu mammary tumor-initiating cells predicts clinical outcome for human HER2+:ERα- breast cancer.

Liu JC, Voisin V, Bader GD, Deng T, Pusztai L, Symmans WF, Esteva FJ, Egan SE, Zacksenhaus E. Liu JC, et al. Among authors: symmans wf. Proc Natl Acad Sci U S A. 2012 Apr 10;109(15):5832-7. doi: 10.1073/pnas.1201105109. Epub 2012 Mar 28. Proc Natl Acad Sci U S A. 2012. PMID: 22460789 Free PMC article.

2

Breast cancer heterogeneity: evaluation of clonality in primary and metastatic lesions.

Symmans WF, Liu J, Knowles DM, Inghirami G. Symmans WF, et al. Hum Pathol. 1995 Feb;26(2):210-6. doi: 10.1016/0046-8177(95)90039-x. Hum Pathol. 1995. PMID: 7860051 Free article.

3

Global gene expression changes during neoadjuvant chemotherapy for human breast cancer.

Buchholz TA, Stivers DN, Stec J, Ayers M, Clark E, Bolt A, Sahin AA, Symmans WF, Hess KR, Kuerer HM, Valero V, Hortobagyi GN, Pusztai L. Buchholz TA, et al. Among authors: symmans wf. Cancer J. 2002 Nov-Dec;8(6):461-8. doi: 10.1097/00130404-200211000-00010. Cancer J. 2002. PMID: 12500855

4

Chemotherapy-induced apoptosis and Bcl-2 levels correlate with breast cancer response to chemotherapy.

Buchholz TA, Davis DW, McConkey DJ, Symmans WF, Valero V, Jhingran A, Tucker SL, Pusztai L, Cristofanilli M, Esteva FJ, Hortobagyi GN, Sahin AA. Buchholz TA, et al. Among authors: symmans wf. Cancer J. 2003 Jan-Feb;9(1):33-41. doi: 10.1097/00130404-200301000-00007. Cancer J. 2003. PMID: 12602766

5

Molecular profiles of invasive mucinous and ductal carcinomas of the breast: a molecular case study.

Pusztai L, Sotiriou C, Buchholz TA, Meric F, Symmans WF, Esteva FJ, Sahin A, Liu ET, Hortobagi GN. Pusztai L, et al. Among authors: symmans wf. Cancer Genet Cytogenet. 2003 Mar;141(2):148-53. doi: 10.1016/s0165-4608(02)00737-9. Cancer Genet Cytogenet. 2003. PMID: 12606133

6

Correlation between HER-2 expression and response to neoadjuvant chemotherapy with 5-fluorouracil, doxorubicin, and cyclophosphamide in patients with breast carcinoma.

Zhang F, Yang Y, Smith T, Kau SW, McConathy JM, Esteva FJ, Kuerer HM, Symmans WF, Buzdar AU, Hortobagyi GN, Pusztai L. Zhang F, et al. Among authors: symmans wf. Cancer. 2003 Apr 1;97(7):1758-65. doi: 10.1002/cncr.11245. Cancer. 2003. PMID: 12655533 Free article.

7

Total RNA yield and microarray gene expression profiles from fine-needle aspiration biopsy and core-needle biopsy samples of breast carcinoma.

Symmans WF, Ayers M, Clark EA, Stec J, Hess KR, Sneige N, Buchholz TA, Krishnamurthy S, Ibrahim NK, Buzdar AU, Theriault RL, Rosales MF, Thomas ES, Gwyn KM, Green MC, Syed AR, Hortobagyi GN, Pusztai L. Symmans WF, et al. Cancer. 2003 Jun 15;97(12):2960-71. doi: 10.1002/cncr.11435. Cancer. 2003. PMID: 12784330 Free article.

8

Gene expression profiles obtained from fine-needle aspirations of breast cancer reliably identify routine prognostic markers and reveal large-scale molecular differences between estrogen-negative and estrogen-positive tumors.

Pusztai L, Ayers M, Stec J, Clark E, Hess K, Stivers D, Damokosh A, Sneige N, Buchholz TA, Esteva FJ, Arun B, Cristofanilli M, Booser D, Rosales M, Valero V, Adams C, Hortobagyi GN, Symmans WF. Pusztai L, et al. Among authors: symmans wf. Clin Cancer Res. 2003 Jul;9(7):2406-15. Clin Cancer Res. 2003. PMID: 12855612

9

The Her-2/neu gene and protein in breast cancer 2003: biomarker and target of therapy.

Ross JS, Fletcher JA, Linette GP, Stec J, Clark E, Ayers M, Symmans WF, Pusztai L, Bloom KJ. Ross JS, et al. Among authors: symmans wf. Oncologist. 2003;8(4):307-25. doi: 10.1634/theoncologist.8-4-307. Oncologist. 2003. PMID: 12897328 Free article. Review.

10

Phase I and II study of exisulind in combination with capecitabine in patients with metastatic breast cancer.

Pusztai L, Zhen JH, Arun B, Rivera E, Whitehead C, Thompson WJ, Nealy KM, Gibbs A, Symmans WF, Esteva FJ, Booser D, Murray JL, Valero V, Smith TL, Hortobagyi GN. Pusztai L, et al. Among authors: symmans wf. J Clin Oncol. 2003 Sep 15;21(18):3454-61. doi: 10.1200/JCO.2003.02.114. J Clin Oncol. 2003. PMID: 12972520 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

302 results

Search Page

Filters